Engensis pain treatment checked for Long-Term safety
NCT ID NCT04055090
First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 37 times
Summary
This study followed 101 people who had previously received either the experimental drug Engensis or a placebo for painful diabetic neuropathy. No new treatment was given; researchers simply monitored participants for 6 months to see if any safety issues or lasting pain relief appeared. The goal was to understand whether Engensis remains safe and effective over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arizona Research Center
Phoenix, Arizona, 85023, United States
-
Center for Clinical Research
San Francisco, California, 94115, United States
-
Clinical Research of West Florida
Tampa, Florida, 33603, United States
-
Clinical Trials, Inc.
Little Rock, Arkansas, 72205, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
EVMS (Eastern Virginia Medical School)
Norfolk, Virginia, 23510, United States
-
Innovative Research of West Florida
Clearwater, Florida, 33756, United States
-
Nerve and Muscle Center of Texas
Houston, Texas, 77030, United States
-
Neurological Research Institute
Santa Monica, California, 90404, United States
-
Northern California Research
Sacramento, California, 95821, United States
-
Rainier Clinical Research Center, Inc.
Renton, Washington, 98057, United States
-
Raleigh Neurology Associates, P.A.
Raleigh, North Carolina, 27607, United States
-
The Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
University of Florida McKnight Brain Institute
Gainesville, Florida, 32611, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Engensis (VM202)
What this could lead to
If successful, this could show that Engensis provides lasting pain relief for people with painful diabetic neuropathy.
What could go wrong
This is a follow-up study with no new treatment given, so it cannot prove effectiveness. Results depend on the original trial's outcomes, which may not be positive.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.